Palliative effect of (131)I-MIBG in relapsed neuroblastoma after autologous peripheral blood stem cell transplantation / 소아과
Korean Journal of Pediatrics
;
: 214-218, 2008.
Article
in English
| WPRIM
| ID: wpr-94452
ABSTRACT
Neuroblastoma is one of the most common extracranial solid tumor of childhood, and treatment of refractory neuroblastoma remains a significant clinical problem. Iodine-131-metaiodobenzylguanidine ((131)I-MIBG) therapy is an alternative approach to treat stage IV neuroblastoma. We report the palliative effect of (131)I-MIBG in three cases of relapsed neuroblastoma after autologous peripheral blood stem cell transplantation. (131)I-MIBG is an effective and relatively nontoxic palliative therapy resulting in reduction of pain and prolongation of survival.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Palliative Care
/
Peripheral Blood Stem Cell Transplantation
/
Neuroblastoma
Language:
English
Journal:
Korean Journal of Pediatrics
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS